What is Tango Therapeutics's PP&E (net)?

Tango Therapeutics (TNGX) reported PP&E (net) of $6.38M in Q1 2026.

How has Tango Therapeutics's PP&E (net) changed year-over-year?

Tango Therapeutics's PP&E (net) decreased by 15.4% year-over-year, from $7.54M to $6.38M.

What is the long-term trend for Tango Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Tango Therapeutics's PP&E (net) has grown at a 12.4% compound annual growth rate (CAGR), from $3.82M to $6.87M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Tango Therapeutics TNGX PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers SquibbBMY

$7.66B+6.2%

AmgenAMGN

$8.22B+23.0%

Gilead SciencesGILD

$5.64B+4.0%

ExelixisEXEL

$95.52M-17.0%

Cogent Biosciences, Inc.COGT

$5.3M-17.9%

CG OncologyCGON

$15.07M+5,610%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Enterprise value$4.43B+2,204%

P/S79.9×+74.4×

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's PP&E (net)?: Tango Therapeutics (TNGX) reported PP&E (net) of $6.38M in Q1 2026.
How has Tango Therapeutics's PP&E (net) changed year-over-year?: Tango Therapeutics's PP&E (net) decreased by 15.4% year-over-year, from $7.54M to $6.38M.
What is the long-term trend for Tango Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Tango Therapeutics's PP&E (net) has grown at a 12.4% compound annual growth rate (CAGR), from $3.82M to $6.87M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.